GTS5:PALB2-related cancer predisposition syndrome (PALB2): Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 149: | Line 149: | ||
==Additional Information== | ==Additional Information== | ||
Pathogenic variants in PALB2 are associated with hereditary breast cancer susceptibility and confer a moderate-to-high lifetime risk of breast cancer, with risk estimates approaching those observed for BRCA2 in some families (Antoniou et al., 2014; Tischkowitz et al., 2017). Female carriers have an estimated 35–58% lifetime risk of breast cancer by age 70, with risk modified by family history and other genetic or environmental factors. PALB2 pathogenic variants are also associated with an increased risk of pancreatic cancer, and emerging evidence suggests a possible association with ovarian cancer, although penetrance for non-breast cancers remains lower and less well defined compared with BRCA1/2 (Yang et al., 2020; NCCN, 2024). Biallelic pathogenic variants in PALB2 cause Fanconi anemia subtype N, characterized by congenital anomalies, bone marrow failure, and childhood cancer predisposition, highlighting the gene’s essential role in DNA repair (Reid et al., 2007). From a molecular standpoint, PALB2 encodes a critical partner of BRCA1 and BRCA2 within the homologous recombination (HR) DNA repair pathway. Loss-of-function variants result in homologous recombination deficiency (HRD), which has therapeutic relevance, as tumors harboring germline or somatic PALB2 pathogenic variants may demonstrate sensitivity to PARP inhibitors and platinum-based chemotherapy (Park et al., 2021; Mateo et al., 2019). Identification of a pathogenic PALB2 variant has important clinical management implications, including enhanced breast cancer surveillance (e.g., annual breast MRI), consideration of risk-reducing strategies, and cascade testing for at-risk relatives, in accordance with established professional guidelines (NCCN, 2024). | |||
==Links== | ==Links== | ||
https://www.ncbi.nlm.nih.gov/clinvar/?term=%22PALB2%22%5BGENE%5D&redir=gene | https://www.ncbi.nlm.nih.gov/clinvar/?term=%22PALB2%22%5BGENE%5D&redir=gene | ||